Abstract:Proteolysis targeting chimera (PROTAC) technology, a groundbreaking strategy for degradation of pathogenic proteins by hijacking of the ubiquitin-proteasome-system has become a promising strategy in drug design. However, the real-time monitoring and visualization of protein degradation processes have been long-standing challenges in the realm of drug development. In this research, we sought to amalgamate the highly efficient protein-degrading capabilities of PROTAC technology with the visualization attributes of fluorescent probes, with the potential to pave the path for the design and development of a novel class of visual PROTACs. These novel PROTACs uniquely possess both fluorescence imaging and therapeutic characteristics, all with the goal of enabling real-time observations of protein degradation processes. Our approach involved the utilization of a high ER-targeting fluorescent probe, previously reported in our laboratory, which served as a warhead that specifically binds to the protein of interest (POI). Additionally, a VHL ligand for recruiting E3 ligase and linkers of various lengths were incorporated to synthesize a series of novel ER-inherent fluorescence PROTACs. Among them, compound A3 demonstrated remarkable efficiency in degrading ERα proteins (DC 50 = 0.12 μM) and displaying exceptional anti-proliferative activity against MCF-7 cells (IC 50 = 0.051 μM). Furthermore, it exhibited impressive fluorescence imaging performance, boasting an emission wavelength of up to 582 nm, a Stokes shift of 116 nm, and consistent optical properties. These attributes make it especially suitable for the real-time, in situ tracking of ERα protein degradation processes, thus may serve as a privileged visual theranostic PROTAC for ERα + breast cancer. This study not only broadens the application spectrum of PROTAC technology but also introduces a novel approach for real-time visualization of protein degradation processes, ultimately enhancing the diagnostic and treatment efficacy of PROTACs.

Making Protein Degradation Visible: Discovery of Theranostic PROTACs for Detecting and Degrading NAMPT

PROTACs: an Emerging Targeting Technique for Protein Degradation in Drug Discovery

Addressing the Enzyme-independent tumor-promoting function of NAMPT via PROTAC-mediated degradation

Discovery of an Activatable Near-Infrared Fluorescent and Theranostic PROTAC for Tumor-Targeted Detecting and Degrading of BRD4

Fluorescence theranostic PROTACs for real-time visualization of ERα degradation

Engineering POLYTAC Nanoparticles for Bioorthogonal Click Reaction-Enforced Protein Degradation and Breast Cancer Therapy

Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy.

A Rapid and Accurate Method for Evaluating the Degradation of Pan-Akt in Cells by PROTACs Using NanoLuc Luciferase.

Precise Modulation of Protein Degradation by Smart PROTACs

Small Molecule PROTACs in Targeted Therapy: an Emerging Strategy to Induce Protein Degradation.

The Present and Future of Novel Protein Degradation Technology

Stimuli-activatable PROTACs for precise protein degradation and cancer therapy

Enzyme-catalyzed Activation of Pro-PROTAC for Cell-selective Protein Degradation

Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope

Photoswitchable PROTACs for Reversible and Spatiotemporal Regulation of NAMPT and NAD+

Stimuli‐Responsive PROTACs for Controlled Protein Degradation

Discovery of Highly Potent Nicotinamide Phosphoribosyltransferase Degraders for Efficient Treatment of Ovarian Cancer

Expanding the Horizons of Targeted Protein Degradation: A Non-Small Molecule Perspective

PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy

Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation

Discovery of novel protein degraders based on bioorthogonal reaction-driven intracellular self-assembly strategy